메뉴 건너뛰기




Volumn 66, Issue 1, 2014, Pages 42-54

Adjuvant chemotherapy for invasive bladder cancer: A 2013 updated systematic review and meta-analysis of randomized trials

Author keywords

Adjuvant chemotherapy; Meta analysis; Muscle invasive bladder cancer; Perioperative chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; PACLITAXEL; VINBLASTINE;

EID: 84902117954     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.08.033     Document Type: Review
Times cited : (329)

References (42)
  • 1
    • 84871920581 scopus 로고    scopus 로고
    • Epidemiology and risk factors of urothelial bladder cancer
    • M. Burger, J.W. Catto, and G. Dalbagni et al. Epidemiology and risk factors of urothelial bladder cancer Eur Urol 63 2013 234 241
    • (2013) Eur Urol , vol.63 , pp. 234-241
    • Burger, M.1    Catto, J.W.2    Dalbagni, G.3
  • 3
    • 33745609548 scopus 로고    scopus 로고
    • Adjuvant chemotherapy of bladder cancer
    • F. Boccardo, and L. Palmeri Adjuvant chemotherapy of bladder cancer Ann Oncol 17 Suppl 5 2006 v129 v132
    • (2006) Ann Oncol , vol.17 , Issue.SUPPL. 5
    • Boccardo, F.1    Palmeri, L.2
  • 4
    • 84870571565 scopus 로고    scopus 로고
    • ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings
    • C.N. Sternberg, J. Bellmunt, and G. Sonpavde et al. ICUD-EAU International Consultation on Bladder Cancer 2012: chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings Eur Urol 63 2013 58 66
    • (2013) Eur Urol , vol.63 , pp. 58-66
    • Sternberg, C.N.1    Bellmunt, J.2    Sonpavde, G.3
  • 5
    • 21844450899 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data: Advanced bladder cancer (ABC) meta-analysis collaboration
    • discussion 205-6
    • C.L. Vale Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data: advanced bladder cancer (ABC) meta-analysis collaboration Eur Urol 48 2005 202 206 discussion 205-6
    • (2005) Eur Urol , vol.48 , pp. 202-206
    • Vale, C.L.1
  • 6
    • 79961028436 scopus 로고    scopus 로고
    • Multi-institutional quality of-care initiative for nonmetastatic, muscle-invasive, transitional cell carcinoma of the bladder [abstract 240]
    • A. Feifer, J.M. Taylor, and M. Shouery et al. Multi-institutional quality of-care initiative for nonmetastatic, muscle-invasive, transitional cell carcinoma of the bladder [abstract 240] J Clin Oncol 29 Suppl 7 2011
    • (2011) J Clin Oncol , vol.29 , Issue.SUPPL. 7
    • Feifer, A.1    Taylor, J.M.2    Shouery, M.3
  • 7
    • 84859419726 scopus 로고    scopus 로고
    • Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: Results of a feasibility questionnaire
    • M. Burger, P. Mulders, and W. Witjes Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire Eur Urol 61 2012 1070 1071
    • (2012) Eur Urol , vol.61 , pp. 1070-1071
    • Burger, M.1    Mulders, P.2    Witjes, W.3
  • 9
    • 21844432174 scopus 로고    scopus 로고
    • Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration
    • discussion 199-201
    • C.L. Vale Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Eur Urol 48 2005 189 201 discussion 199-201
    • (2005) Eur Urol , vol.48 , pp. 189-201
    • Vale, C.L.1
  • 10
    • 33745056502 scopus 로고    scopus 로고
    • Adjuvant chemotherapy for invasive bladder cancer (individual patient data)
    • Advanced Bladder Cancer (ABC) Meta-analysis Collaboration
    • Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Adjuvant chemotherapy for invasive bladder cancer (individual patient data) Cochrane Database Syst Rev 2006 CD006018
    • (2006) Cochrane Database Syst Rev , pp. 006018
  • 11
    • 84857509409 scopus 로고    scopus 로고
    • Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: An Italian, multicenter, randomized phase III trial
    • F. Cognetti, E.M. Ruggeri, and A. Felici et al. Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial Ann Oncol 23 2012 695 700
    • (2012) Ann Oncol , vol.23 , pp. 695-700
    • Cognetti, F.1    Ruggeri, E.M.2    Felici, A.3
  • 13
    • 79955969084 scopus 로고    scopus 로고
    • Randomized phase III trial comparing adjuvant paclitaxel/gemcitabine/ cisplatin (PGC) to observation in patients with resected invasive bladder cancer: Results of the Spanish Oncology Genitourinary Group (SOGUG) 99/01study [abstract LBA4518]
    • L.G. Paz-Ares, E. Solsona, and E. Esteban et al. Randomized phase III trial comparing adjuvant paclitaxel/gemcitabine/cisplatin (PGC) to observation in patients with resected invasive bladder cancer: results of the Spanish Oncology Genitourinary Group (SOGUG) 99/01study [abstract LBA4518] J Clin Oncol 28 2010 18
    • (2010) J Clin Oncol , vol.28 , pp. 18
    • Paz-Ares, L.G.1    Solsona, E.2    Esteban, E.3
  • 14
    • 80052737876 scopus 로고    scopus 로고
    • Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status
    • W.M. Stadler, S.P. Lerner, and S. Groshen et al. Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status J Clin Oncol 29 2011 3443 3449
    • (2011) J Clin Oncol , vol.29 , pp. 3443-3449
    • Stadler, W.M.1    Lerner, S.P.2    Groshen, S.3
  • 15
    • 0028950013 scopus 로고
    • Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: Long-term results of a controlled prospective study and further clinical experience
    • DOI 10.1097/00005392-199501000-00019
    • M. Stockle, W. Meyenburg, and S. Wellek et al. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience J Urol 153 1995 47 52 (Pubitemid 24379794)
    • (1995) Journal of Urology , vol.153 , Issue.1 , pp. 47-52
    • Stockle, M.1    Meyenburg, W.2    Wellek, S.3    Voges, G.E.4    Rossmann, M.5    Gertenbach, U.6    Thuroff, J.W.7    Huber, C.8    Hohenfellner, R.9
  • 16
    • 33644797618 scopus 로고    scopus 로고
    • Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer
    • J. Lehmann, L. Franzaring, J. Thuroff, S. Wellek, and M. Stockle Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer BJU Int 97 2006 42 47
    • (2006) BJU Int , vol.97 , pp. 42-47
    • Lehmann, J.1    Franzaring, L.2    Thuroff, J.3    Wellek, S.4    Stockle, M.5
  • 18
    • 0032583387 scopus 로고    scopus 로고
    • Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
    • DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0. CO;2-8
    • M.K. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834 (Pubitemid 28562978)
    • (1998) Statistics in Medicine , vol.17 , Issue.24 , pp. 2815-2834
    • Parmar, M.K.B.1    Torri, V.2    Stewart, L.3
  • 20
    • 33845571913 scopus 로고    scopus 로고
    • Random-effects model for meta-analysis of clinical trials: An update
    • DOI 10.1016/j.cct.2006.04.004, PII S1551714406000486
    • R. DerSimonian, and R. Kacker Random-effects model for meta-analysis of clinical trials: an update Contemp Clin Trials 28 2007 105 114 (Pubitemid 44937874)
    • (2007) Contemporary Clinical Trials , vol.28 , Issue.2 , pp. 105-114
    • DerSimonian, R.1    Kacker, R.2
  • 22
    • 0037186429 scopus 로고    scopus 로고
    • Advanced methods in meta-analysis: Multivariate approach and meta-regression
    • DOI 10.1002/sim.1040
    • H.C. van Houwelingen, L.R. Arends, and T. Stijnen Advanced methods in meta-analysis: multivariate approach and meta-regression Stat Med 21 2002 589 624 (Pubitemid 34141379)
    • (2002) Statistics in Medicine , vol.21 , Issue.4 , pp. 589-624
    • Van Houwelingen, H.C.1    Arends, L.R.2    Stijnen, T.3
  • 23
    • 84859001212 scopus 로고    scopus 로고
    • The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
    • J.P. Higgins, D.G. Altman, and P.C. Gotzsche et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2011 d5928
    • (2011) BMJ , vol.343 , pp. 5928
    • Higgins, J.P.1    Altman, D.G.2    Gotzsche, P.C.3
  • 24
    • 68549101842 scopus 로고    scopus 로고
    • The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration
    • A. Liberati, D.G. Altman, and J. Tetzlaff et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
    • (2009) BMJ , vol.339 , pp. 2700
    • Liberati, A.1    Altman, D.G.2    Tetzlaff, J.3
  • 26
    • 0030049159 scopus 로고    scopus 로고
    • A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer
    • discussion 499-500
    • F. Freiha, J. Reese, and F.M. Torti A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer J Urol 155 1996 495 499 discussion 499-500
    • (1996) J Urol , vol.155 , pp. 495-499
    • Freiha, F.1    Reese, J.2    Torti, F.M.3
  • 27
    • 0242405666 scopus 로고    scopus 로고
    • Perioperative chemotherapy in advanced bladder cancer - Part II: Adjuvant treatment
    • DOI 10.1159/000072983
    • T. Otto, P.J. Goebell, and H. Rubben Perioperative chemotherapy in advanced bladder cancer - Part II: adjuvant treatment Onkologie 26 2003 484 488 (Pubitemid 37409895)
    • (2003) Onkologie , vol.26 , Issue.5 , pp. 484-488
    • Otto, T.1    Goebell, P.J.2    Rubben, H.3
  • 28
    • 0025822201 scopus 로고
    • The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial
    • discussion 464-7
    • D.G. Skinner, J.R. Daniels, and C.A. Russell et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial J Urol 145 1991 459 464 discussion 464-7
    • (1991) J Urol , vol.145 , pp. 459-464
    • Skinner, D.G.1    Daniels, J.R.2    Russell, C.A.3
  • 30
    • 81255204165 scopus 로고    scopus 로고
    • Intention-to-treat concept: A review
    • S.K. Gupta Intention-to-treat concept: a review Perspect Clin Res 2 2011 109 112
    • (2011) Perspect Clin Res , vol.2 , pp. 109-112
    • Gupta, S.K.1
  • 32
    • 84899483711 scopus 로고    scopus 로고
    • National Cancer Institute ClinicalTrials.gov Web site
    • National Cancer Institute. Ad/HER2/neu dendritic cell cancer vaccine testing. ClinicalTrials.gov Web site. www.clinicaltrials.gov/show/NCT1730118.
    • Ad/HER2/neu Dendritic Cell Cancer Vaccine Testing
  • 33
    • 84864423349 scopus 로고    scopus 로고
    • A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer
    • J.J. Meeks, J. Bellmunt, and B.H. Bochner et al. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer Eur Urol 62 2012 523 533
    • (2012) Eur Urol , vol.62 , pp. 523-533
    • Meeks, J.J.1    Bellmunt, J.2    Bochner, B.H.3
  • 34
    • 0037866815 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis
    • Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis Lancet 361 2003 1927 1934
    • (2003) Lancet , vol.361 , pp. 1927-1934
  • 35
    • 34548144894 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy for invasive bladder cancer
    • Neoadjuvant chemotherapy for invasive bladder cancer Cochrane Database Syst Rev 2005 CD005246
    • (2005) Cochrane Database Syst Rev , pp. 005246
  • 36
    • 79955731409 scopus 로고    scopus 로고
    • Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer
    • M.P. Porter, M.C. Kerrigan, B.M. Donato, and S.D. Ramsey Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer Urol Oncol 29 2011 252 258
    • (2011) Urol Oncol , vol.29 , pp. 252-258
    • Porter, M.P.1    Kerrigan, M.C.2    Donato, B.M.3    Ramsey, S.D.4
  • 37
    • 34447095141 scopus 로고    scopus 로고
    • Low Incidence of Perioperative Chemotherapy for Stage III Bladder Cancer 1998 to 2003: A Report From the National Cancer Data Base
    • DOI 10.1016/j.juro.2007.03.101, PII S0022534707007495
    • K.A. David, M.I. Milowsky, J. Ritchey, P.R. Carroll, and D.M. Nanus Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base J Urol 178 2007 451 454 (Pubitemid 47030482)
    • (2007) Journal of Urology , vol.178 , Issue.2 , pp. 451-454
    • David, K.A.1    Milowsky, M.I.2    Ritchey, J.3    Carroll, P.R.4    Nanus, D.M.5
  • 38
    • 56249148146 scopus 로고    scopus 로고
    • Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: A high-volume tertiary cancer center experience
    • S.M. Donat, A. Shabsigh, and C. Savage et al. Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience Eur Urol 55 2009 177 186
    • (2009) Eur Urol , vol.55 , pp. 177-186
    • Donat, S.M.1    Shabsigh, A.2    Savage, C.3
  • 39
    • 0021417031 scopus 로고
    • Cisplatin as adjunctive treatment for invasive bladder carcinoma: Tolerance and toxicities
    • A.B. Einstein Jr., W. Shipley, J. Coombs, K.B. Cummings, M.S. Soloway, and I. Hawkins Cisplatin as adjunctive treatment for invasive bladder carcinoma: tolerance and toxicities Urology 23 1984 110 117
    • (1984) Urology , vol.23 , pp. 110-117
    • Einstein Jr., A.B.1    Shipley, W.2    Coombs, J.3    Cummings, K.B.4    Soloway, M.S.5    Hawkins, I.6
  • 40
    • 0020540673 scopus 로고
    • Adjuvant chemotherapy with doxorubicin (Adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy
    • B. Richards, J.R. Bastable, and L. Freedman et al. Adjuvant chemotherapy with doxorubicin (Adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy Brit J Urol 55 1983 386 391 (Pubitemid 13076311)
    • (1983) British Journal of Urology , vol.55 , Issue.4 , pp. 386-391
    • Richards, B.1    Bastable, J.R.G.2    Freedman, L.3
  • 42
    • 84863897662 scopus 로고    scopus 로고
    • Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987
    • J. Bellmunt, H. von der Maase, and G.M. Mead et al. Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987 J. Clin. Oncol 30 2012 1107 1113
    • (2012) J. Clin. Oncol , vol.30 , pp. 1107-1113
    • Bellmunt, J.1    Von Der Maase, H.2    Mead, G.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.